AMPK-Activator-13

CAS No. 1243184-62-4

AMPK-Activator-13( MDK 4624 | AMPKα1 activator C13 | C13, Compound 13. )

Catalog No. M10984 CAS No. 1243184-62-4

A potent, allosteric, α1-selective small molecule activator of AMPK (EC50=20 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AMPK-Activator-13
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, allosteric, α1-selective small molecule activator of AMPK (EC50=20 nM).
  • Description
    A potent, allosteric, α1-selective small molecule activator of AMPK (EC50=20 nM); inhibits de novo lipogenesis in cellular and animal models of hyperlipidemia; the cell-permeable prodrug of compound 2 (AMPK-Activator-2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDK 4624 | AMPKα1 activator C13 | C13, Compound 13.
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1243184-62-4
  • Formula Weight
    431.334
  • Molecular Formula
    C17H22NO10P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)C(OCOP(C1=CC=C(C(C2)=NOC2=O)O1)(OCOC(C(C)C)=O)=O)=O
  • Chemical Name
    (((5-(5-oxo-4,5-dihydroisoxazol-3-yl)furan-2-yl)phosphoryl)bis(oxy))bis(methylene) bis(2-methylpropanoate)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hunter RW, et al. Chem Biol. 2014 Jul 17;21(7):866-79. 2. Gómez-Galeno JE, et al. ACS Med Chem Lett. 2010 Aug 30;1(9):478-82.
molnova catalog
related products
  • ZLN-024

    A novel AMPK allosteric activator that has no effect on mitochondrial function or the ADP/ATP ratio; directly activate recombinant AMPK α1β1γ1 and its homologue α2β1γ1 with EC50 of 0.42 uM and 0.95 uM, respectively.

  • Kudinoside D

    Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.

  • BC1618

    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.